Thursday 23 August 2018

BioLargo Announces Craft Brewery Pre-Commercial Pilot Study Project Funded by Innovative Conservation Program (ICP)


WESTMINSTER, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- BioLargo, Inc. (OTCQB:BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, announced that the Innovative Conservation Program (ICP) (http://mwdh2o.com/ICP) had granted funding to support a pre-commercial pilot water treatment study project at the Joshua Tree Brewery, a brewery under construction in Joshua Tree, California, slated to open in late 2018. The pilot project will feature BioLargo's Advanced Oxidation System (AOS) and Aquacycl's BioElectrochemical Treatment Technology (BETT™) to demonstrate that these combined technologies are capable of providing effective and cost-efficient treatment of the brewery's wastewater to meet California discharge standards and avoid regulatory non-compliance. The project's goal is to allow the wastewater to be used for landscaping irrigation.

Aquacycl provides microbial fuel cell technologies for packaged wastewater treatment plants that can eliminate primary sludge, recover energy as direct electricity (no methane), and enable onsite water reuse at operational costs that are 50%-80% lower than incumbent technologies and at competitive capital costs.

BioLargo's AOS complements the Aquacycl technology by providing high fidelity disinfection and elimination of recalcitrant organic compounds and a lower cost and lower energy requirement than other "polishing step" technologies such as UV and ozone. BETT™ and AOS together stand to offer breweries and other food and beverage facilities a robust and cost-efficient option for wastewater treatment to meet regulatory discharge standards at a significant price reduction to current systems.
















"BioLargo is extremely pleased to have met Aquacycl via the Maritime Alliance and join them to provide an important synergistic solution to advance the cause of water conservation and water reuse for the Food and Beverage industry. We are thankful for the continued support of innovation by the Innovative Conservation Program and for its funding partners' commitment to drive new water technologies developed by companies like ours," commented Dennis Calvert, CEO of BioLargo.

"Aquacycl is thrilled to be working with BioLargo, Joshua Tree Brewery to demonstrate cost-effective, modular, and scalable solutions for the treatment of brewery wastewater, and evaluate new enabling technologies for onsite reuse," commented Orianna Bretschger, CEO, Aquacycl.

About BioLargo, Inc.
BioLargo, Inc. is an innovative technology incubator and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We incubate disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS", a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

About Aquacycl, LLC.
Founded in 2016 and headquartered in San Diego, California, Aquacycl™ (www.aquacycl.com) develops and manufactures the patented BioElectrochemical Treatment Technology (BETT™) for use in distributed wastewater treatment plants. The BETT™ systems can eliminate up to 80% of total suspended solids, recover energy as direct electricity (no methane), and enable onsite water reuse at operational costs that are 50%-95% lower than incumbent technologies. Aquacycl provides BETT™ systems through competitive equipment leasing and service plans; and strives to be the leading global provider of bioelectrochemical technologies for decentralized industrial, agricultural, military and emerging market wastewater treatment applications.
Contact Information

Dennis Calvert

President and CEO

BioLargo, Inc.

949-643-9540 x2

No comments:

Post a Comment